Bayer's Bluetooth-enabled auto-injector, designed & developed with Bang & Olufsen Medicom
Bayer Healthcare has introduced the BETACONNECT™ auto-injector, the first component of an innovative, new dose-delivery system for its Betaferon® multiple sclerosis (MS) treatment.
Thundersoft and Trustonic join forces
Leading Android integrator and trusted technology provider form partnership to enhance smartphone and app security.
Cambridge Index rises 1.9%
The Cambridge Index added 1.9% or 313.21 points to 16,575.0, as only one of the top ten index heavyweights reported weekly losses.
Sepura appoints new Group HR Director
Sepura plc has today announced the appointment of James Griffiths into a newly created senior executive role of Group HR Director.
AstraZeneca’s novel antibiotic candidate given Fast Track status by US FDA
AstraZeneca today announced that the US Food and Drug Administration (FDA) has designated its novel investigational drug AZD0914 as a Qualified Infectious Disease Product (QIDP) and awarded its development programme Fast Track status for the treatment of uncomplicated gonorrhoea, which is increasingly resistant to existing antibiotics and poses a serious global public health threat.
AstraZeneca updates on the rapid progress of its oncology pipeline at ASCO 2014
AstraZeneca provided an update on the rapid development of its oncology pipeline at a briefing for analysts and investors on 2 May 2014, as compelling data from over 40 scientific abstracts related to AstraZeneca and MedImmune investigational medicines were presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago.
WaveFX film crew returns home from European Tour
Cambridge video company WaveFX has been very much in demand this year, filming and streaming events across the UK and Europe to a global audience.
First for Cleantech – live link with New Delhi explores energy from waste
Cambridge Cleantech is undertaking the ‘first’ event of its kind next Tuesday (June 10th), by linking consecutive speakers in a live link-up between Cambridge and New Delhi to explore the issue of energy from waste and recycling. To celebrate after the event at The Future Business Centre, Cambridge, speakers and delegates will be able to tuck in to an Indian buffet feast.
How will we move freight in future? David Cebon speaks
Professor David Cebon will explain the options for improving the efficiency of freight transport, in a free talk in Cambridge tomorrow evening (Weds June 4th).
Electric cars reinvented - IDTechEx predicts $178.9 billion market
IDTechEx finds that the global sale of hybrid and pure electric cars will triple to $178.9 billion in 2024 as they are transformed in most respects.
Advanced materials: one of the UK's 'eight great technologies' for future growth
University of Cambridge materials scientist Professor Mark Blamire and engineer Professor Bill O’Neil discuss how research in Cambridge is helping to advance the material world.
Nanotechnology takes on diabetes
A sensor which can be used to screen for diabetes in resource-poor settings has been developed by researchers and tested in diabetic patients, and will soon be field tested in sub-Saharan Africa.
Huntingdon tops Amazon.co.uk’s most well-read towns and cities list for the fourth year
To celebrate the start of the summer holiday reading season, Amazon.co.uk has revealed its fourth annual list of the Top 10 Most Well-Read Towns and Cities in the UK. Huntingdon heads the list, while Cambridge comes a respectable sixth.
Avacta Analytical sponsors 5th annual Protein Formulation Development and Drug Delivery Forum
Avacta Analytical is pleased to announce its sponsorship of this year’s Protein Formulation Development and Drug Delivery Forum in Barcelona, Spain.
New people help drive forward economic growth
The Greater Cambridge Greater Peterborough Enterprise Partnership (LEP) is welcoming two new faces this June to help support economic growth in the local area.
125 years of the Carl Zeiss Foundation
German Chancellor Angela Merkel acknowledges the historic importance and promising future orientation of the Carl Zeiss Foundation.
Breakfast at Alconbury as Cambridge Network spreads its wings
It's not too late to sign up for Cambridge Network's breakfast networking event tomorrow (Weds June 4th) at Alconbury, near Huntingdon, on the ever popular topic of sales.
Manage your stress! Novel product launch to balance your cortisol levels
Bupa reports that 6 million people in the UK have been stressed for a year or longer. Chronic stress affects a variety of functions in the body and cortisol, the main stress hormone, causes damage if it is produced in excess (or insufficiently). A new dietary supplement could play a role in the non-drug treatment of stress-related issues.
CUH Urology department declared one of the best in the world
Cambridge University Hospitals Urology department has been singled out as one of the best in the world.
Syrris offers fully automated pressure reactors
The Atlas Potassium Pressure System, a modular 3 bar pressure reactor from Syrris that can be controlled manually or automatically, has been designed specifically for high vacuum processes and applications requiring elevated pressures such as hydrogenations and carbonylations.
Somersault provides full video coverage for BT Sport Industry Awards
Somersault's team donned tuxedos and hit the red carpet recently to provide full video coverage of the annual BT Sport Industry Awards.
DefiniGEN announces closing of £2.3 million Series A fundraising
DefiniGEN Ltd, a leading provider of stem cell life science products and services, today announced the final closing of its Series A funding round. The latest £1 million ($1.6 million) placement for ordinary shares brings to a close a cumulative total for the round of £2.28 million ($3.83 million), which will support the international expansion of the business and the commercial launch of new…
Positive data released on medicine combination for treatment of ovarian cancer
As part of the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), Dr Joyce Liu (on 31 May 2014) presented data on a Phase II study conducted by the American National Cancer Institute (NCI), comparing the efficacy and tolerability of olaparib and cediranib in combination to olaparib alone, for the treatment of women with recurrent platinum-sensitive high-grade serous ovarian…
Horizon completes acquisition of CombinatoRx service business and assets from Zalicus Inc.
The acquisition of a revenue generating and complementary business establishes Horizon’s headquarters in North America.
Mantracourt load cell amplifier enables robot stability
Hexapod robot designers choose the Mantracourt ICA load cell amplifier for the detection of forces on each leg.